Products

MOZI TPS
Manteia Technologies Co., Ltd.
Oncology AI
Mozi is the next-generation treatment planning solution, combining precision, speed, and adaptability. With built-in patient-specific goals, real-time adaptive planning, and intelligent automated planning, Mozi streamlines your workflow and evolves with future innovation.
ARTAssistant
Manteia Technologies Co., Ltd.
Oncology AI
ARTAssistant by Manteia Technologies Co., Ltd. is an FDA-cleared AI-powered software for adaptive radiation therapy, focusing on image processing, registration, and contouring to enhance precision and efficiency in cancer treatment.
AccuContour
Manteia Technologies Co., Ltd.
Oncology AI
AccuContour by Manteia Technologies is an AI-driven auto-contouring solution for radiation oncology, enhancing efficiency and precision in treatment planning through automated OAR and tumor target contouring, image fusion, plan review, and dose accumulation.

See all 3 products →

About Manteia Technologies Co.

Manteia Technologies Co. is a healthcare AI company specializing in intelligent software solutions for radiation oncology. Their offerings are designed to enhance the precision, efficiency, and automation of cancer treatment through the integration of artificial intelligence, big data, and advanced algorithms. The company’s product suite includes tools for AI-driven auto-contouring, treatment planning, and quality assurance.

For physicians, Manteia’s technology aims to streamline complex workflows in radiation therapy. Products like AccuContour provide an AI platform for planning assistance, including automatic delineation of organs-at-risk and tumors, image fusion and registration, and plan review and comparison. AccuLearning is a deep learning platform that allows clinics to train customized AI models using their own data, facilitating site-specific adaptation and integration into existing clinical workflows. Additionally, their MOZI Treatment Planning System (TPS) is utilized for planning external beam irradiation with photon beams for malignant or benign diseases, incorporating advanced features like Monte Carlo dose calculation. The AccuCheck system offers vendor-independent quality assurance throughout the treatment process, ensuring data integrity, parameter consistency, and independent dose calculations.

Focus Areas

radiation oncology artificial intelligence data analysis adaptive radiotherapy medical imaging deep learning treatment planning quality assurance

Business Intelligence

TechnologyAI operating system, deep learning, advanced algorithms, cloud-native (for some components like AccuLearning which runs on local servers but integrates into the Manteia ecosystem)

What Physicians Need to Know

Precision Radiotherapy & Adaptive Radiotherapy
Manteia Technologies specializes in intelligent, adaptive, and precision-driven solutions for cancer treatment. Their MOZI Treatment Planning System (TPS) redefines radiotherapy by enabling patient-specific customization and adaptation daily, prior to each treatment session. This system can transform a standard linear accelerator (LINAC) into an online adaptive radiotherapy system, making adaptive radiotherapy benefits accessible in routine clinical practice without complex infrastructure. MOZI TPS integrates image processing, auto-contouring, re-planning, quality assurance (QA), and treatment delivery within minutes for a seamless end-to-end online Adaptive RT workflow.
Radiation Oncology Software & AI-based Auto-contouring
Manteia offers a comprehensive radiation therapy solution covering image-based treatment planning, QA/QC, and Adaptive Radiation Therapy (ART). Their AccuContour™ software provides AI auto-contouring for organs-at-risk (OARs), lymph nodes, and tumor targets, significantly boosting efficiency by over 90%. It supports user self-trained models and has been validated in over 1200 worldwide centers. AccuContour also features fusion and registration for various imaging modalities (CT, MRI, PET-CT, 4D images) for accurate multimodal alignment.
Treatment Planning
The MOZI TPS is a next-generation treatment planning system that combines precision, speed, and adaptability. It integrates core functionalities such as image processing, structure delineation, treatment plan design, optimization, and evaluation. MOZI TPS employs Monte Carlo methods for dose calculation and deep learning for automatic contouring and planning optimization. It supports various treatment techniques including 3DCRT, IMRT, VMAT, SBRT, and CBCT/MRI-guided online adaptation.
QA/QC
Manteia's QA Solution, including AccuCheck and QA Pro, provides vendor-independent and unbiased quality assurance throughout the entire treatment process. AccuCheck offers Monte Carlo-based secondary dose verification, log-file dose delivery checks, and plan integrity checks. QA Pro optimizes machine QA workflows with automated task scheduling, data collection, trend analysis, and predictive maintenance. The QA solutions are powered by Monte Carlo algorithms and AI-driven analytics, ensuring accuracy and reliability.
Medical Imaging & Deep Learning
Manteia's software supports advanced image processing, including automatic rigid and deformable registration of multi-modality images (CT, MRI, PET-CT, 4D). AccuLearning is a deep learning-powered platform for localized, small-sample training in radiation oncology, allowing clinics to build customized AI models with their own data. This platform requires minimal data (as few as 1 data case) and no programming experience, bridging the gap from research to clinical integration.
Monte Carlo Algorithms
Manteia extensively utilizes Monte Carlo algorithms in its MOZI TPS for high-precision dose calculation in complex cases and in its QA solutions for gold-standard accuracy in secondary dose verification. Monte Carlo simulation is considered the gold standard for radiation dose calculation due to its unmatched accuracy in heterogeneous tissues and complex geometries.
Physician Tip

Manteia Technologies offers solutions designed to significantly enhance efficiency and precision in radiation oncology. Physicians can leverage AccuContour for rapid, AI-driven auto-contouring of OARs and tumor targets, potentially reducing contouring time to under a minute and boosting overall efficiency by over 90%. The MOZI TPS enables real-time adaptive radiotherapy, allowing for daily patient-specific plan adjustments based on anatomical changes, which can be completed within minutes. This 'see-and-treat' approach ensures higher precision and safety in treatment delivery. Furthermore, AccuLearning provides a unique opportunity for clinics to train customized AI models using their own patient data, even with small datasets and without programming expertise, fostering site-specific adaptation and continuous improvement of AI models. The vendor-independent nature of Manteia's solutions ensures seamless integration into existing workflows and compatibility with various LINACs and imaging systems.

Manteia's solutions are designed to be vendor-independent and fully interoperable, seamlessly integrating into existing radiation oncology workflows. Their software supports various imaging modalities (CT, MRI, PET-CT, 4D) for fusion and registration and is compatible with different accelerator types. The QA solutions support all radiotherapy equipment, including LINACs, brachytherapy, TOMO, CyberKnife, proton, CT, and MR, and enable data integration from various QA devices. MOZI TPS is FDA approved as a Class II medical device and holds CE certification.

Products by Manteia Technologies Co.

3 products in the directory

MOZI TPS
Manteia Technologies Co., Ltd.
Oncology AI
Mozi is the next-generation treatment planning solution, combining precision, speed, and adaptability. With built-in patient-specific goals, real-time adaptive planning, and intelligent automated planning, Mozi streamlines your workflow and evolves with future innovation.
ARTAssistant
Manteia Technologies Co., Ltd.
Oncology AI
ARTAssistant by Manteia Technologies Co., Ltd. is an FDA-cleared AI-powered software for adaptive radiation therapy, focusing on image processing, registration, and contouring to enhance precision and efficiency in cancer treatment.
AccuContour
Manteia Technologies Co., Ltd.
Oncology AI
AccuContour by Manteia Technologies is an AI-driven auto-contouring solution for radiation oncology, enhancing efficiency and precision in treatment planning through automated OAR and tumor target contouring, image fusion, plan review, and dose accumulation.

What the Web Says

Manteia Technologies Co. is a company that specializes in AI-driven solutions for radiation therapy and oncology, including treatment planning systems and QA solutions. Their products, such as MOZI TPS and AccuContour, have received FDA approval and are designed to enhance precision, efficiency, and automation in cancer treatment. While there are no direct reviews for "Manteia Technologies Co." on G2, Glassdoor, Capterra, or Reddit, information from their official website and FDA documents highlights the features and capabilities of their products. There were some reviews for similarly named companies like "Mainthia Technologies" and "Metanoia Technologies" on Indeed, but these are distinct entities.

Overall: Mixed

Strengths

  • AI auto-contouring for organs at risk, lymph nodes, and tumor targets.
  • Supports user self-trained models for contouring.
  • Advanced image registration for accurate multimodal alignment (CT, MRI, PET-CT, 4D images).
  • Vendor-independent review of various treatment plans (3D, IMRT, VMAT, Tomo).
  • Monte Carlo-based dose calculation for high precision and efficiency.
  • Automated QA workflow with real-time feedback and reporting.

Limitations

  • Lack of readily available customer or employee reviews on major platforms like G2, Glassdoor, Capterra, and Reddit.
  • Limited public information regarding company culture or employee experiences.
  • No specific details on pricing models or potential integration challenges from user perspectives.
  • Absence of direct user feedback on product usability or customer support experiences.
  • The company's products are intended for use in limited markets and may not be available everywhere.
  • No information on potential downsides or areas for improvement from a user standpoint.

Based on reviews from: Manteia Official Website, FDA.gov, Google Cloud Vertex AI Search, Oxford Scientific

Last updated: 2026-10-24

Videos

News, demos, and interviews about Manteia Technologies Co..

Loading videos...

Videos load interactively. If none appear, search YouTube for Manteia Technologies Co. →

View all on YouTube

Press & Coverage

Tema Sinergie
MOZI: Bringing Innovation into Clinical Practice
This article details a distribution agreement between PTW Freiburg and Manteia Technologies, facilitated by Tema Sinergie, to bring Manteia's MOZI solution for radiotherapy treatment planning to over 40 countries in EMEA.
2026-09
PitchBook
Manteia 2026 Company Profile: Valuation, Funding & Investors
This profile provides an overview of Manteia Technologies, including its founding year, employee count, funding rounds, and key investors, highlighting its focus on AI and big data for cancer treatment.
2026-10
HealthTech Alpha
Manteia (Manteia) Company Profile: Funding, Investors & Partnerships
This company profile outlines Manteia's commitment to innovations in adaptive radiotherapy through AI, data analysis, and advanced algorithms, listing its products AccuContour, AccuPlan, and AccuLearning.
2026-10
VCBeat
VCBeat has learned that Manteia Technologies Co., Ltd. (hereinafter referred to as “Manteia”) recently completed a B-round financing of RMB 110 million.
Manteia Technologies completed a Series B financing round of RMB 110 million, led by Zhongke Haichuang, with participation from Yangming Capital and industrial cooperation partners, to develop full-line domestically produced radiotherapy products.
2024-01
Manteia Medical
Italian Media Hails "Epochal Turning Point": MOZI TPS Brings Adaptive Radiotherapy 4.0 to Leading Hospital
Responsible Research Hospital in Italy launched Online Adaptive Radiotherapy (oART) powered by Manteia's MOZI TPS, an AI-driven treatment planning platform, marking its entry into the Radiotherapy 4.0 era.
2025-04
MDPI
Systematic Review of Commercial Deep Learning-Based Auto-Segmentation Software for Prostate Cancer Radiation Therapy Planning
This systematic review evaluates various commercial deep learning-based auto-segmentation software for prostate cancer radiation therapy planning, including Manteia Medical Technologies Co. AccuContour.
2025-03
FDA.gov
510(k) Premarket Notification K221706: AccuContour
This FDA clearance document for Manteia Technologies Co., Ltd.'s AccuContour device details its indications for use in radiation oncology departments for image registration and segmentation to aid in treatment planning.
2023-03
FDA.gov
510(k) Premarket Notification K223724: MOZI TPS
This FDA clearance document for Manteia Technologies Co., Ltd.'s MOZI TPS outlines its use for planning radiotherapy treatments for patients with malignant or benign diseases using external beam irradiation with photon beams.
2023-07

Frequently Asked Questions

Manteia Technologies Co. focuses on enhancing precision and adaptive radiotherapy by developing AI-based solutions for radiation oncology. Their products aim to improve the accuracy of treatment delivery, streamline workflows, and enable more personalized patient care through advanced algorithms and software. This includes addressing challenges in treatment planning, auto-contouring, and quality assurance.
Manteia's AI-based auto-contouring and deep learning solutions are designed for seamless integration with existing radiation oncology software and medical imaging systems. They typically offer APIs or compatible data formats to ensure interoperability with various PACS, DICOM-compliant devices, and treatment planning systems. This allows for a smooth transition and minimizes disruption to current clinical workflows.
Manteia Technologies Co. prioritizes regulatory compliance for all its radiation oncology software and AI algorithms. They adhere to stringent quality management systems and pursue necessary certifications such as FDA clearance in the United States and CE Mark in Europe. This ensures their products meet the highest standards for safety, efficacy, and data privacy in a clinical setting.
Manteia Technologies Co. offers flexible pricing structures for its products, which may include both subscription-based models and perpetual licenses, depending on the specific software and client needs. Pricing typically covers software licenses, implementation support, and ongoing technical assistance. Comprehensive support packages are usually available, encompassing training, regular updates, and dedicated customer service to ensure optimal product performance and user satisfaction.
Manteia Technologies Co. is committed to long-term innovation and market presence in the radiation oncology space. They actively pursue strategic partnerships with leading academic institutions, research centers, and other healthcare technology providers to further develop and validate their solutions. These collaborations demonstrate their dedication to advancing precision radiotherapy and ensuring the stability and continuous evolution of their product offerings.
Manteia's Monte Carlo algorithms are employed in treatment planning and QA/QC to provide highly accurate dose calculations, particularly in complex anatomical regions or for advanced treatment techniques. These algorithms simulate the transport of radiation particles at a microscopic level, offering a more precise understanding of dose distribution compared to traditional analytical methods. This leads to improved treatment accuracy, reduced toxicity to healthy tissues, and enhanced confidence in quality assurance processes.
Manteia Technologies Co. provides comprehensive training and ongoing support to ensure effective implementation and utilization of their software by clinical staff. This typically includes initial on-site or virtual training sessions, detailed user manuals, and access to a dedicated support team for technical assistance and troubleshooting. They also offer regular software updates and educational resources to keep users informed of new features and best practices, fostering a smooth integration into clinical workflows.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]

Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.